Effect on bone health of estrogen preparations in premenopausal women with anorexia nervosa: A systematic review and meta-analyses

International Journal of Eating Disorders

Volumn 43, Issue 3, 2010, Pages 218-225

  Sim, Leslie A ^a   McGovern, Lauren ^a   Elamin, Mohamed B ^a   Swiglo, Brian A ^a   Erwin, Patricia J ^a   Montori, Victor M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Amenorrhea; Anorexia nervosa; Bone mineral density; Estrogen; Meta analyses; Premenopause

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; ETHINYLESTRADIOL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; NORGESTIMATE; PLACEBO; PRASTERONE;

AMENORRHEA; ANOREXIA NERVOSA; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FEMALE; FEMUR NECK; FRACTURE; HUMAN; LUMBAR SPINE; META ANALYSIS; PREMENOPAUSE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; BONE DENSITY; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; PREMENOPAUSE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 77949420686     PISSN: 02763478     EISSN: 1098108X     Source Type: Journal    
DOI: 10.1002/eat.20687     Document Type: Review

References (33)

1. Katzman DK. Medical complications in adolescents with anorexia nervosa: A review of the literature. Int J Eating Disord 2005;37 Suppl(S52-S59):587-589.
2. Herzog DB, Keller MB, Lavori PW. Outcome in anorexia nervosa and bulimia nervosa: A review of the literature. J Nervous Mental Disease 1988;176:131-143.
3. Strober M, Freeman R, Morrell W. The long-term course of severe anorexia nervosa in adolescents: Survival of recovery, relapse, and outcome predictors over 10-15 years in a prospective study. Int J Eating Disord 1997;22:339-360.
4. Rigotti NA, Nussbaum SR, Herzog DB, Neer RM. Osteoporosis in women with anorexia nervosa. N Engl J Med 1984;311:1601-1606.
5. Ward A, Brown N, Treasure J. Persistent osteopenia after recovery from anorexia nervosa. Int J Eating Disord 1997;22:71-75.
6. Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical course of osteoporosis in anorexia nervosa. JAMA 1991;265:1133-1138.
7. Haberland CA, Seddick D, Marcus R, Bachrach L. A physician survey of therapy for exercise associated amenorrhea: A brief report. Clin J Sport Med 1995;5:246-250.
8. Robinson E, Bachrach LK, Katzman DK. Use of homone replacement therapy to reduce the risk fo osteopenia in adolescent girls with anorexia nervosa. J Adolesc Health 2000;26:343-348.
9. Marslew U, Overgaard K, Riis BJ, Christiansen C. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: Long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Obstetrics Gynecol 1992;79:202-210.
10. Mosekilde L, Beck-Nielsen H, Sorensen OH, Nielsen SP, Charles P, Vestergaard P, et al. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - Results of the Danish Osteoporosis Prevention Study. Maturitas 2000;36:181-193.
11. Register TC, Jayo MJ, Jerome CP. Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skelatally immature young adult female monkeys. Osteroporosis Int 1997;7:348-353.
12. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002;87:2883-2891.
13. Strokosch GR, Friedman AJ, Wu S-C, Kamin M. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: A doubleblind, placebo-controlled study. J Adolesc Health 2006;39: 819-827.
14. Grinspoon S, Thomas E, Pitts S, Gross E, Mickley D, Miller K, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Int Med 2000;133:790-794.
15. Misra M, Prabhakaran R, Miller KK, Goldstein MA, Mickley D, Clauss L, et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 2008;93:1231-1237.
16. Liu SL, Lebrun CM. Effect of oral contraceptives and hormone replacment therapy on bone mineral density in premenopausal and perimenopausal women: A systematic review. Brit J Sports Med 2006;40:11-24.
17. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, Ontario: The Ottawa Health Research Institute. http://www. ohri.ca/programs/clinical-epidemiology/oxford.htm. Accessed July 15, 2008.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
19. Higgins JP, Thompson SG. Quantifying hetrogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
20. Altman DG, Bland JM. Interaction revisited: The difference between two estimates. BMJ 2003;326:219.
21. Gordon CM, Estherann GS, Emans J, Feldman HA, Goodman E, Becker KA, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: A randomized trial. J Clin Endocrinol Metab 2002;87:4935-4941.
22. Klibanski A, Biller BMK, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995;80:898-904.
23. Golden NH, Lanzkowsky L, Schebendach J, Palestro CJ, Jacobson MS, Shenker IR. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatric Adolesc Gynecol 2002;15:135-143.
24. Munoz-Calvo MT, Barrios V, De Alvaro MTG, Lefort M, Mendez-Davila C, Argente J, et al. Maintained malnutrition produces a progressive decrease in (OPG)/RANKL ratio and leptin levels in patients with anorexia nervosa. Scand J Clin Lab Invest 2007;67:387-393.
25. Castelo-Branco C, Vicente JV, Pons F, Martinez de Osaba M, Casals E, Vanrell JA. Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives. J Reprod Med 2001;41:875-879.
26. Cobb KL, Bachrach LK, Sowers M, Nieves J, Greendale GA, Kent KK, et al. The effect of oral contraceptives on bone mass and stress fractures in female runners. Med Sci Sports Exercise 2007;39:1464-1473.
27. Gibson JH, Mitchell A, Reeve J, Harries MG. Treatment of reduced bone mineral density in athletic amenorrhea: A pilot study. Osteoporosis Int 1999;10:284-289.
28. Hergenroeder AC, Smith EOB, Shypailo R, Jones LA, Klish WJ, Ellis K. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstetrics Gynecol 1997;176:1017-1025.
29. Warren MP, Brooks-Gunn J, Fox RP, Holderness CC, Hyle EP, Hamilton WG, et al. Persistent osteopenia in ballet dancers with amenorrhea and delayed menarche despite hormone therapy: A longitudinal study. Fertil Steril 2003;80:398-404.
30. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C, et al. IX: Summary of meta-analyses of the therapies for postmenopausal osteoporosis endocrine reviews. 2002;23:570-578.
31. Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333:597-600.
32. Swiglo BA, Murad MH, Schunemann HJ, Kunz R, Vigersky RA, Guyatt GH, et al. A case for clarity, consistency, and helpfulness: State-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 2008;93:666-673.
33. Frye CA. An overview of oral contraceptives: Mechanism of action and clinical use. Neurology 2006;66(6, Suppl 3):S29-S36.